$0.0549
+0 (+0%)
At Close: Feb 20, 2026
Notice: Technical analysis is hidden due to insufficient data.
There can be multiple reasons for our algorithm to not provide conclusion. One of them can be low or no liquidity.
If you think this is not correct, please
ADAP Performance
FAQ
What is the symbol for Adaptimmune Therapeutics plc Stock and on which exchange is it traded?
The symbol for Adaptimmune Therapeutics plc is ADAP and it is traded on the NASDAQ (NASDAQ Stock Exchange).
Should I buy or sell Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
How to buy Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.
What's the current price of Adaptimmune Therapeutics plc Stock?
As of the end of day on the Feb 20, 2026, the price of an Adaptimmune Therapeutics plc (ADAP) share was $0.0549.
What is the 52-week high and low for Adaptimmune Therapeutics plc Stock?
The 52-week high for Adaptimmune Therapeutics plc Stock is $0.620 and the 52-week low is $0.0403.
What is the market capitalization of Adaptimmune Therapeutics plc Stock?
As of the Feb 20, 2026, the market capitalization of Adaptimmune Therapeutics plc is 75.158M.
Sign In
Buy ADAP